X0202 SCHEDULE 13G/A 0001094891-26-000176 0000909440 XXXXXXXX LIVE 1 Common Stock, par value $0.001 per share 06/30/2026 0001624326 PAVmed Inc. 70387R502 360 MADISON AVENUE 360 MADISON AVENUE NEW YORK NY 10017 Rule 13d-1(c) NAGELBERG DAVID S X1 699778.00 0.00 699778.00 0.00 699778.00 N 8.8 IN David S. Nagelberg 2003 Revocable Trust Dtd. 07/02/03 FL 474542.00 0.00 474542.00 0.00 474542.00 5.9 OO Trust PAVmed Inc. 360 MADISON AVENUE, 360 MADISON AVENUE, NEW YORK, NEW YORK, 10017. This Amendment to Schedule 13G is filed by the David S. Nagelberg 2003 Revocable Trust Dtd. 07/02/03 ("Trust") and David Nagelberg ("Mr. Nagelberg," and together with the Trust, the "Reporting Persons"). Mr. Nagelberg controls the Trust. The Reporting Persons have entered into a Joint Filing Agreement, a copy of which is filed as Exhibit 99.1 to the initial Schedule 13G, pursuant to which such Reporting Persons have agreed to file the Schedule 13G and all amendments thereto jointly in accordance with the provisions of Rule 13d-1(k) of the Act. Any disclosures herein with respect to persons other than the Reporting Persons are made on information and belief after making inquiry to the appropriate party. The filing of this Schedule 13G should not be construed in and of itself as an admission by any Reporting Person as to beneficial ownership of the shares of Common Stock reported herein. The principal business address of each of the Reporting Persons is c/o Graubard Miller, 405 Lexington Avenue, 44th Floor, New York, New York 10174. The Trust is a trust governed by the laws of Florida. Mr. Nagelberg is a citizen of the United States. Y As of August 13, 2026, the Trust beneficially owns 474,542 shares of Common Stock. Mr. Nagelberg may be deemed to beneficially own the shares of Common Stock held by the Trust, because Mr. Nagelberg controls the Trust. As of August 13, 2026, Mr. Nagelberg beneficially owns an additional 225,236 shares of Common Stock. As of August 13, 2026, the Trust beneficially owns 5.9% of the outstanding shares of Common Stock. As of August 13, 2026, Mr. Nagelberg beneficially owns 8.8% of the outstanding shares of Common Stock. The percentage of beneficial ownership is calculated based on 7,995,918 shares of Common Stock outstanding as of August 13, 2026, as set forth in the Company's quarterly report on Form 10-Q filed on August 13, 2026. Trust: 474,542 shares Mr. Nagelberg: 699,778 shares Trust: 0 shares Mr. Nagelberg: 0 shares Trust: 474,542 shares Mr. Nagelberg: 699,778 shares Trust: 0 shares Mr. Nagelberg: 0 shares Y Y Y Y Y N By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11. 99.1 Joint Filing Agreement (https://www.sec.gov/Archives/edgar/data/909440/000109489126000176/99_1_jointfilingagreement.txt). NAGELBERG DAVID S /s/ David Nagelberg 08/13/2026 David S. Nagelberg 2003 Revocable Trust Dtd. 07/02/03 /s/ David Nagelberg 08/13/2026